Chapters Transcript Video Advancing Health Access- Heath Back to Symposium Please welcome to the stage, Caitlin Heath. Hi, good evening, everyone. Um, please continue eating your dinners. Um, I know that there are some delicious looking desserts in the corner, um, but it's an honor to be with you tonight. My name is Caitlin Heath. I'm the director of healthcare policy and market access here at BD. Um, and I have the honor of talking about something that is really core to our DNA, um, and it's certainly part of our strategy, and that is our commitment to advancing health access, um, and in particular our commitment to improving vascular outcomes by ensuring that patients and providers have access to the diagnosis and the treatment that they need for vascular care. So I always feel extremely fortunate um to get to work at BED. We are one of the largest medical device companies, um, medical technology companies in the world. You heard Rema mention. Um, we operate in over 190 countries and we make more than 34 billion products every year, so I like to say there's not a part of healthcare that we don't touch, um, and in fact we often measure our impact not in days, not in hours, but actually in seconds because there's 1000 products from BD that touch patients and healthcare providers every single second of every day around the world. And in order to do this, we know that the innovation that Andrew will be talking about later, the scale of our, um, production, it really doesn't matter if our technology isn't making its way to the people who need it most. And so in order to expand access we really focus in three areas. One is our technology and innovation, which you heard Reema, um, talk about the breadth of that. Secondly, we can't do this in a vacuum. So we have partnerships not only with our customers but with NGOs, patient advocacy organizations, medical societies, and other organizations across the world. And then finally for us to really enable the 3.4 million vascular disease intervention that we do every single year, we need to make sure that there's the infrastructure in place, that we have clinicians who are not only there but also trained and have the education that they need, and that the patients can get from screening to diagnosis to treatment in a timely and effective manner. And so our investment in health system strengthening is another area where we're focused, and we've actually shifted our giving over the past two years so that more than 85% of our dollars from the Beauty Foundation and social investing goes to increasing health access in areas like vascular disease where we have expertise. So I wanted just to share a few of the ways that we're partnering with organizations that we're working on our own programs in order to get them to scale and demonstrate impact, um, specifically to ensure access to appropriate screening, diagnosis and treatment for vascular disease, and our goal is again to partner and to scale these programs to improve diagnosis and care. So one partnership I'm very excited about that we began about 2 years ago is our sponsorship of the American Heart Association's National PAD Action Plan. So this is a coordinated campaign to drive awareness on PAD both to patients and providers by meeting them where they're at, and AHA uses their data insights to actually geo-target their campaign in order for patients to understand what is PAD, what are the risks, um, and showing them either in physicians' offices, videos, reaching out on social media, and again using culturally appropriate language. They also have resources for for professionals as well and you can just see some of the numbers on the screen, but it was a highly successful campaign and I'm really excited hot off the press, um, that we are going to be re-upping the sponsorship and we're going to continue to partner with the AHA over the next two years as they further drive into the campaign using the new insights that they gathered, um, to reach more communities and more patients. So in addition to working with partners to advance their goals, we also have some in-house programs, um, specifically I wanted to talk a little bit about the Love Your Limbs PAD awareness campaign. So this is a campaign that we've had, I think, for over a decade. Somebody in beauty, yeah, I could probably give you the exact year, but we're really looking again to educate and raise awareness for patients on PAD so that they can get appropriate diagnosis and care. And today we've really split this program into three important areas. One, advancing access to screening. Secondly, is having data to drive insights, and finally, advancing policy. This year we launched the Love Your Limbs Community Screening initiative, and this is an initiative where we partner with organizations, so health and community organizations with health care professionals such as yourselves to provide free ABI screenings for patients and communities who need them. And I'm really excited to have Kim here. Um, one of the ways that we work with this program is that after a screening we give patients access to the Global PAD Association's toll-free number so that they can be connected with a PAD specialist navigator to help them get to that next point of their care, whether that is diagnosis or treatment. Secondly, we're lucky to have an amazing team of data analysts here at BD and health economists, and then they've been working on a PAD amputation risk heat map. So unlike some of the other heat maps that are out here, this is actually using predictive analytics to model where amputation risk is highest at a zip code and a county by county level. So we're able to look at publicly available data such as the AHA amputation data, um, social deprivation indices, census data to understand some of these comorbidities and map them out across the US, but then we are also overlaying this data with private data. Where we're looking at procedure rates and where they're happening, um, and how that compares then to the PAD amputation risks so we're really excited for this work we'll actually be presenting at several conferences over the next couple of months, um, and so a lot more to come with the insights that we're gathering from that. And then finally, being in this space, we know that we have a responsibility to advocate for patients and physicians to really look at the system barriers to receiving PAD care. And so our team in DC, whether that's looking at educating policy makers, advancing legislation, or working like things on appropriations, um, so that we're highlighting the risk that this disease has and the impact it has on Americans, um, we're partnering with organizations to make sure that we're beside them and making sure that we're educating again, uh, members of Congress. On what um what we can do to better the care for these patients and in particular we have upcoming in February we're helping to put on a congressional briefing specifically on PAD where we'll be again educating members of Congress we're partnering with Sky, the cardiovascular, um, coalition and other organizations, um, to help put on that event. And then finally BD is a really old company we've been around for 125 years, so we have a lot of legacy programs that we've scaled and we also have demonstrated their impact. Um, one of these programs is the BD Helping Build Healthy Communities program. So this program was started back in 2013. And we've worked directly with some longstanding partners through Direct Relief and the National Association of Free and Charitable Clinics to provide grants to clinics who are doing innovative things when it comes to advancing patient care and thinking about delivery of. Care in different ways, um, we started with, uh, diabetic patients, and we actually have a program where we've showed that by increasing, um, time with pharmacists and advancing their care that we can significantly reduce A1C levels in this patient population. And so today we're evaluating the program's, um, impact on clinical outcomes for patients with PAD by better managing their comorbidities and we're also exploring how we can better serve patients with venous disease in these areas as well. So if any of this interests you, um, I'm here the rest of the night we love to pick your brains, understand what you're seeing in the communities um we're obviously interested in partnerships and learning more about the communities that we're serving, so please find me afterwards um would love to talk to you either later tonight or tomorrow. Published Created by
Content on this site is intended for United States Healthcare Professionals Only
